Unlock stock picks and a broker-level newsfeed that powers Wall Street.
5.49
+0.37
+(7.23%)
At close: April 2 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -1.06 | -1.01 | -3.92 | -1.73 |
| Low Estimate | -1.13 | -1.06 | -4.4 | -2.32 |
| High Estimate | -1.02 | -0.98 | -3.56 | -1.41 |
| Year Ago EPS | -1.11 | -1.25 | -5.29 | -3.92 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | 27.91M | 37.2M | 163.74M | 350.08M |
| Low Estimate | 24.74M | 34.2M | 148.7M | 326.45M |
| High Estimate | 31.5M | 39.55M | 172M | 381.1M |
| Year Ago Sales | 1.91M | 7.32M | 55.25M | 163.74M |
| Sales Growth (year/est) | 1,359.83% | 407.88% | 196.35% | 113.80% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.22 | -1.24 | -1.47 | -1.08 |
| EPS Actual | -1.11 | -1.25 | -1.05 | -1.05 |
| Difference | 0.11 | -0.01 | 0.42 | 0.03 |
| Surprise % | 9.02% | -0.81% | 28.33% | 2.78% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.06 | -1.01 | -3.92 | -1.73 |
| 7 Days Ago | -1.03 | -0.93 | -3.9 | -1.65 |
| 30 Days Ago | -1.01 | -0.92 | -3.73 | -1.59 |
| 60 Days Ago | -1.01 | -0.92 | -3.56 | -1.2 |
| 90 Days Ago | -1.01 | -0.92 | -3.39 | -1.2 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 2 | 1 |
| Up Last 30 Days | 1 | -- | 2 | -- |
| Down Last 7 Days | 1 | 2 | 1 | -- |
| Down Last 30 Days | 1 | 2 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PHAT | 4.50% | 19.36% | 25.90% | 55.87% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Reiterates | Guggenheim: Buy to Buy | 4/2/2025 |
| Reiterates | Needham: Buy to Buy | 4/2/2025 |
| Maintains | Goldman Sachs: Neutral to Neutral | 3/10/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/7/2025 |
| Reiterates | Needham: Buy to Buy | 3/6/2025 |
| Reiterates | Needham: Buy to Buy | 1/10/2025 |
Related Tickers
ALMS Alumis Inc.
9.84
+35.91%
EWTX Edgewise Therapeutics, Inc.
15.52
-22.90%
DAWN Day One Biopharmaceuticals, Inc.
7.97
+4.73%
STOK Stoke Therapeutics, Inc.
6.60
+5.94%
SWTX SpringWorks Therapeutics, Inc.
46.52
+11.08%
IDYA IDEAYA Biosciences, Inc.
16.35
+10.70%
KYMR Kymera Therapeutics, Inc.
26.36
+4.46%
SNDX Syndax Pharmaceuticals, Inc.
12.97
+7.99%
VRNA Verona Pharma plc
60.29
+2.99%
BCYC Bicycle Therapeutics plc
8.05
+2.55%